- Tytuł:
-
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody
ipilimumab in viremic HIV patients. - Autorzy:
- Źródło:
- PloS one [PLoS One] 2018 Jun 07; Vol. 13 (6), pp. e0198158. Date of Electronic Publication: 2018 Jun 07 (Print Publication: 2018).
- Typ publikacji:
- Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
CTLA-4 Antigen/*immunology
HIV Infections/*drug therapy
HIV-1/*immunologyIpilimumab /*administration & dosage
Viremia/*drug therapy
Adult ; CD4 Lymphocyte Count ; CTLA-4 Antigen/antagonists & inhibitors ; Dose-Response Relationship, Drug ; Female ; HIV Infections/immunology ; HIV Infections/metabolism ; HIV Infections/virology ; Humans ;Ipilimumab /adverse effects ;Ipilimumab /pharmacokinetics ; Male ; Maximum Tolerated Dose ; Middle Aged ; RNA, Viral/blood ; Viremia/immunology ; Viremia/metabolism
Czasopismo naukowe